AVITA Medical, Inc. (RCEL)

AVITA Medical Stock Forecast

Stock Price Forecast

The 4 analysts that cover AVITA Medical stock have a consensus rating of "Buy" and an average price target of $11.75, which forecasts a 241.57% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $21.

Price Target: $11.75 (+241.57%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$11.75	$14	$21
Change	+16.28%	+241.57%	+306.98%	+510.47%

* Price targets were last updated on Nov 7, 2025.

Analyst Ratings

The average analyst rating for AVITA Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	1	1	1	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Zimmerman BTIG	BTIG	Strong Sell → Hold Upgrades n/a	Strong Sell → Hold	Upgrades	n/a	n/a	Nov 20, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $14	Strong Buy	Maintains	$14	+306.98%	Nov 7, 2025
Frank Takkinen Lake Street	Lake Street	Strong Buy → Hold Downgrades $8 → $4	Strong Buy → Hold	Downgrades	$8 → $4	+16.28%	Oct 17, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $14	Strong Buy	Maintains	$14	+306.98%	Oct 17, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $14	Strong Buy	Maintains	$14	+306.98%	Sep 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

72.68M

Increased by 13.12%

from 64.25M

Revenue Next Year

92.71M

Increased by 27.56%

from 72.68M

EPS This Year

-1.51

from -2.39

EPS Next Year

-0.84

from -1.51

Fiscal Year	FY 2021	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	29.23M	33.03M	34.42M	50.14M	64.25M	72.68M	92.71M
Revenue Growth	104.95%	12.98%	4.23%	45.68%	28.14%	13.12%	27.56%
EPS	-1.17	-1.03	-1.07	-1.40	-2.39	-1.51	-0.84
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	76.4M	124.4M
Avg	72.7M	92.7M
Low	68.6M	76.4M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	19.0%	71.1%
Avg	13.1%	27.6%
Low	6.8%	5.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-0.38	-0.18
Avg	-1.51	-0.84
Low	-1.76	-1.50

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.